{
  "generated_at": "2026-02-24T04:25:27.499844+00:00",
  "modalities": [
    "fhir",
    "genomics",
    "notes",
    "dicom"
  ],
  "kg_backend": "dashboard",
  "summary": {
    "n_runs": 5,
    "avg_pass_rate": 0.5667,
    "avg_fail_rate": 0.4333
  },
  "runs": [
    {
      "patient_id": "a29c9b58-4598-ebb8-190a-21345e5af644",
      "patient_meta": {
        "modalities": [
          "fhir"
        ],
        "n_dicom_files": 0,
        "n_variants_loaded": 0,
        "outcome": "deceased"
      },
      "evaluation": {
        "must_verify_count": 6,
        "must_verify_pass_rate": 0.0,
        "must_verify_weak_rate": 0.0,
        "must_verify_fail_rate": 1.0,
        "problem_count": 1,
        "sensitivity_count": 1
      },
      "result": {
        "soap_final": "S: Patient demographics: gender=female, birth_date=1950-12-24\nKnown conditions: Concussion with no loss of consciousness, Appendicitis, History of appendectomy, Prediabetes, Anemia (disorder), Normal pregnancy, Viral sinusitis (disorder), Viral sinusitis (disorder), Normal pregnancy, Miscarriage in first trimester\nMedications: Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet, Ortho Tri-Cyclen 28 Day Pack, Ortho Tri-Cyclen 28 Day Pack, Ortho Tri-Cyclen 28 Day Pack, carvedilol 25 MG Oral Tablet, l\nO: Objective evidence limited\nA: Undifferentiated syndrome requiring additional objective data (hypothesis); Genotype interpretation included as supporting evidence only; Verifier-requested updates addressed\nP: Correlate symptoms with objective findings and timeline; Prioritize evidence-backed differential items; Collect missing objective data for unresolved uncertainty; Apply verifier patch list before release; Keep genotype-dependent recommendations caveated",
        "problem_list_ranked": [
          "Undifferentiated syndrome requiring additional objective data (hypothesis)"
        ],
        "plan_options_ranked_non_prescriptive": [
          "Prioritize evidence-backed differential items",
          "Collect targeted objective diagnostics",
          "Reassess with reconciled cross-modal timeline"
        ],
        "evidence_table": [
          {
            "claim_id": "CLM-0001",
            "claim_text": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "category": "inferred",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Differential item derived from integrated EHR+image narrative"
          },
          {
            "claim_id": "CLM-0002",
            "claim_text": "Objective summary: Objective evidence limited",
            "category": "observed",
            "must_verify": false,
            "status": "pass",
            "evidence_ids": [
              "patient_summary"
            ],
            "resolution": "Objective section maps directly to extracted observations"
          },
          {
            "claim_id": "CLM-0003",
            "claim_text": "Recommended action: Correlate symptoms with objective findings and timeline",
            "category": "recommended",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0004",
            "claim_text": "Recommended action: Prioritize evidence-backed differential items",
            "category": "recommended",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0005",
            "claim_text": "Recommended action: Collect missing objective data for unresolved uncertainty",
            "category": "recommended",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0006",
            "claim_text": "Recommended action: Apply verifier patch list before release",
            "category": "recommended",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0007",
            "claim_text": "Recommended action: Keep genotype-dependent recommendations caveated",
            "category": "recommended",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Plan recommendation from supervisor synthesis"
          }
        ],
        "sensitivity_map": [
          {
            "problem": "Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "sensitivity_class": "medium",
            "fragile_on": [
              "single-modality evidence"
            ]
          }
        ],
        "uncertainty_and_escalation_guidance": "Escalate when evidence remains weak for high-impact recommendations. Escalation to medical doctors is required.",
        "provenance": {
          "patient_id": "a29c9b58-4598-ebb8-190a-21345e5af644",
          "generated_at": "2026-02-24T04:25:10.659131+00:00",
          "pipeline": "medagent_v2_blackboard",
          "tooling": {
            "medgemma": "v2-reporter-medgemma-local",
            "biomcp": "v2-policy-biomcp-sdk-strict-no-fallback",
            "verifier": "v2-rules-only",
            "critic_enabled": false,
            "causal_postcheck": true
          },
          "blackboard": {
            "patient_id": "a29c9b58-4598-ebb8-190a-21345e5af644",
            "revision_id": 2,
            "patient_summary": {
              "timeline": [
                {
                  "t": "1958-06-20T05:02:30-04:00",
                  "encounter_type": "EMER",
                  "ehr_excerpt": "Patient demographics: gender=female, birth_date=1950-12-24\nKnown conditions: Concussion with no loss of consciousness, Appendicitis, History of appendectomy, Prediabetes, Anemia (disorder), Normal pregnancy, Viral sinusitis (disorder), Viral sinusitis (disorder), Normal pregnancy, Miscarriage in first trimester\nMedications: Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet, Ortho Tri-Cyclen 28 D",
                  "imaging_count": 0,
                  "variant_count": 0
                }
              ],
              "key_vitals": [],
              "key_labs": [],
              "phenotype_keywords": []
            },
            "medgemma_report": {
              "findings": [
                "Patient demographics: gender=female, birth_date=1950-12-24\nKnown conditions: Concussion with no loss of consciousness, Appendicitis, History of appendectomy, Prediabetes, Anemia (disorder), Normal pregnancy, Viral sinusitis (disorder), Viral sinusitis (disorder), Normal pregnancy, Miscarriage in first trimester\nMedications: Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet, Ortho Tri-Cyclen 28 Day Pack, Ortho Tri-Cyclen 28 Day Pack, Ortho Tri-Cyclen 28 Day Pack, carvedilol 25 MG Oral Tablet, l"
              ],
              "candidate_assessments": [
                "Undifferentiated syndrome requiring additional objective data (hypothesis)"
              ],
              "supporting_observations": [],
              "notes": [
                "Revision focus applied: Objective/subjective narrative lacks explicit negatives",
                "No genotype assertions included by reporter policy",
                "No literature-based assertions included by reporter policy",
                "MedGemma enabled but inference fallback was applied"
              ]
            },
            "genotype_report": {
              "interpretations": [
                "No genotype variants available"
              ],
              "hypotheses": [],
              "actionability_caveats": [
                "No genotype-derived actionability conclusions"
              ],
              "biomcp_query_count": 0,
              "biomcp_empty_count": 0
            },
            "draft_soap": {
              "subjective": "Patient demographics: gender=female, birth_date=1950-12-24\nKnown conditions: Concussion with no loss of consciousness, Appendicitis, History of appendectomy, Prediabetes, Anemia (disorder), Normal pregnancy, Viral sinusitis (disorder), Viral sinusitis (disorder), Normal pregnancy, Miscarriage in first trimester\nMedications: Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet, Ortho Tri-Cyclen 28 Day Pack, Ortho Tri-Cyclen 28 Day Pack, Ortho Tri-Cyclen 28 Day Pack, carvedilol 25 MG Oral Tablet, l",
              "objective": "Objective evidence limited",
              "assessment": "Undifferentiated syndrome requiring additional objective data (hypothesis); Genotype interpretation included as supporting evidence only; Verifier-requested updates addressed",
              "plan": "Correlate symptoms with objective findings and timeline; Prioritize evidence-backed differential items; Collect missing objective data for unresolved uncertainty; Apply verifier patch list before release; Keep genotype-dependent recommendations caveated",
              "differential_ranked": [
                "Undifferentiated syndrome requiring additional objective data (hypothesis)"
              ],
              "open_questions": [
                "What key negatives are still missing?",
                "Any temporal mismatch between symptoms and imaging findings?",
                "Any high-risk recommendation lacking strong evidence?"
              ],
              "confidence_score": 0.6
            },
            "claims_ledger": [
              {
                "claim_id": "CLM-0001",
                "claim_text": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
                "claim_type": "Inferred",
                "confidence": "Medium",
                "evidence_items": [],
                "reasoning": "Differential item derived from integrated EHR+image narrative",
                "uncertainty": "Requires verifier consistency check",
                "depends_on_claim_ids": []
              },
              {
                "claim_id": "CLM-0002",
                "claim_text": "Objective summary: Objective evidence limited",
                "claim_type": "Observed",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "patient_summary",
                    "source_id": "patient_summary",
                    "quote_or_summary": "Derived from timeline/labs/vitals summary",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Objective section maps directly to extracted observations",
                "uncertainty": "May omit missing negatives",
                "depends_on_claim_ids": []
              },
              {
                "claim_id": "CLM-0003",
                "claim_text": "Recommended action: Correlate symptoms with objective findings and timeline",
                "claim_type": "Recommended",
                "confidence": "Low",
                "evidence_items": [],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0004",
                "claim_text": "Recommended action: Prioritize evidence-backed differential items",
                "claim_type": "Recommended",
                "confidence": "Low",
                "evidence_items": [],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0005",
                "claim_text": "Recommended action: Collect missing objective data for unresolved uncertainty",
                "claim_type": "Recommended",
                "confidence": "Low",
                "evidence_items": [],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0006",
                "claim_text": "Recommended action: Apply verifier patch list before release",
                "claim_type": "Recommended",
                "confidence": "Low",
                "evidence_items": [],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0007",
                "claim_text": "Recommended action: Keep genotype-dependent recommendations caveated",
                "claim_type": "Recommended",
                "confidence": "Low",
                "evidence_items": [],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              }
            ],
            "verifier_report": {
              "status": "FAIL",
              "patch_list": [
                {
                  "claim_id": "N/A",
                  "issue_type": "missing_negative",
                  "message": "Objective/subjective narrative lacks explicit negatives",
                  "suggested_fix": "Add key negatives or document that negatives are unavailable"
                },
                {
                  "claim_id": "CLM-0001",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0003",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Recommended action: Correlate symptoms with objective findings and timeline",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0003",
                  "issue_type": "high_risk_weak_evidence",
                  "message": "Recommendation retained with low confidence",
                  "suggested_fix": "Add guideline/literature support or keep as explicit hypothesis"
                },
                {
                  "claim_id": "CLM-0004",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Recommended action: Prioritize evidence-backed differential items",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0004",
                  "issue_type": "high_risk_weak_evidence",
                  "message": "Recommendation retained with low confidence",
                  "suggested_fix": "Add guideline/literature support or keep as explicit hypothesis"
                },
                {
                  "claim_id": "CLM-0005",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Recommended action: Collect missing objective data for unresolved uncertainty",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0005",
                  "issue_type": "high_risk_weak_evidence",
                  "message": "Recommendation retained with low confidence",
                  "suggested_fix": "Add guideline/literature support or keep as explicit hypothesis"
                },
                {
                  "claim_id": "CLM-0006",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Recommended action: Apply verifier patch list before release",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0006",
                  "issue_type": "high_risk_weak_evidence",
                  "message": "Recommendation retained with low confidence",
                  "suggested_fix": "Add guideline/literature support or keep as explicit hypothesis"
                },
                {
                  "claim_id": "CLM-0007",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Recommended action: Keep genotype-dependent recommendations caveated",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0007",
                  "issue_type": "high_risk_weak_evidence",
                  "message": "Recommendation retained with low confidence",
                  "suggested_fix": "Add guideline/literature support or keep as explicit hypothesis"
                }
              ],
              "check_summary": {
                "claim_count": 7,
                "patch_count": 12
              }
            },
            "citations": [],
            "audit_log": [
              {
                "timestamp_utc": "2026-02-24T04:25:01.344358+00:00",
                "agent": "orchestrator_v2",
                "action": "init_blackboard",
                "details": {
                  "timeline_events": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.586841+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.587225+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.587301+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.587396+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.587672+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 6
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.855269+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 10
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.860112+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.860132+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.860139+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.860253+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:09.860431+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 7
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:10.310407+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 12
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:10.316724+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:10.316743+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:10.316749+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 2
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:10.317733+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:10.317930+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 7
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:10.658884+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 12
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:10.659062+00:00",
                "agent": "orchestrator_v2",
                "action": "max_revisions_reached",
                "details": {
                  "revision": 2,
                  "high_stakes": false,
                  "verifier_status": "FAIL"
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:10.659104+00:00",
                "agent": "orchestrator_v2",
                "action": "causal_postcheck",
                "details": {
                  "findings": 1
                }
              }
            ],
            "escalate_to_doctor": true,
            "critic_report": {}
          }
        }
      },
      "kg": {
        "backend": "dashboard",
        "nodes": [
          {
            "id": "patient",
            "label": "a29c9b58-4598-ebb8-190a-21345e5af644",
            "type": "patient"
          },
          {
            "id": "p1",
            "label": "Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "type": "problem"
          },
          {
            "id": "e1",
            "label": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "type": "evidence"
          },
          {
            "id": "e2",
            "label": "Objective summary: Objective evidence limited",
            "type": "evidence"
          },
          {
            "id": "e3",
            "label": "Recommended action: Correlate symptoms with objective findings and timeline",
            "type": "evidence"
          },
          {
            "id": "e4",
            "label": "Recommended action: Prioritize evidence-backed differential items",
            "type": "evidence"
          },
          {
            "id": "e5",
            "label": "Recommended action: Collect missing objective data for unresolved uncertainty",
            "type": "evidence"
          },
          {
            "id": "e6",
            "label": "Recommended action: Apply verifier patch list before release",
            "type": "evidence"
          },
          {
            "id": "e7",
            "label": "Recommended action: Keep genotype-dependent recommendations caveated",
            "type": "evidence"
          },
          {
            "id": "pl1",
            "label": "Prioritize evidence-backed differential items",
            "type": "plan"
          },
          {
            "id": "pl2",
            "label": "Collect targeted objective diagnostics",
            "type": "plan"
          },
          {
            "id": "pl3",
            "label": "Reassess with reconciled cross-modal timeline",
            "type": "plan"
          },
          {
            "id": "s1",
            "label": "Undifferentiated syndrome requiring additional objective data (hypothesis): medium",
            "type": "sensitivity"
          }
        ],
        "edges": [
          {
            "source": "patient",
            "target": "p1",
            "relation": "has_problem"
          },
          {
            "source": "e1",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e2",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e3",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e4",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e5",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e6",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e7",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "pl1",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "pl2",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "pl3",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "s1",
            "target": "patient",
            "relation": "robustness"
          }
        ]
      }
    },
    {
      "patient_id": "b8dd1798-beef-094d-1be4-f90ee0e6b7d5",
      "patient_meta": {
        "modalities": [
          "fhir",
          "dicom",
          "genomics"
        ],
        "n_dicom_files": 1,
        "n_variants_loaded": 25,
        "outcome": "deceased"
      },
      "evaluation": {
        "must_verify_count": 6,
        "must_verify_pass_rate": 1.0,
        "must_verify_weak_rate": 0.0,
        "must_verify_fail_rate": 0.0,
        "problem_count": 1,
        "sensitivity_count": 1
      },
      "result": {
        "soap_final": "S: Patient demographics: gender=male, birth_date=1925-11-14\nKnown conditions: Chronic paralysis due to lesion of spinal cord, Body mass index 30+ - obesity (finding), Osteoporosis (disorder), Hyperlipidemia, Stroke, Numbness of face (finding), Impaired cognition (finding), Abnormal gait (finding), Silent micro-hemorrhage of brain (disorder), Coronary Heart Disease\nMedications: Simvastatin 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet,\nO: DICOM\nA: Undifferentiated syndrome requiring additional objective data (hypothesis); Genotype interpretation included as supporting evidence only; Verifier-requested updates addressed\nP: Correlate symptoms with objective findings and timeline; Prioritize evidence-backed differential items; Collect missing objective data for unresolved uncertainty; Apply verifier patch list before release; Keep genotype-dependent recommendations caveated",
        "problem_list_ranked": [
          "Undifferentiated syndrome requiring additional objective data (hypothesis)"
        ],
        "plan_options_ranked_non_prescriptive": [
          "Prioritize evidence-backed differential items",
          "Collect targeted objective diagnostics",
          "Reassess with reconciled cross-modal timeline"
        ],
        "evidence_table": [
          {
            "claim_id": "CLM-0001",
            "claim_text": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "category": "inferred",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "medgemma_report"
            ],
            "resolution": "Differential item derived from integrated EHR+image narrative"
          },
          {
            "claim_id": "CLM-0002",
            "claim_text": "Objective summary: DICOM",
            "category": "observed",
            "must_verify": false,
            "status": "pass",
            "evidence_ids": [
              "patient_summary"
            ],
            "resolution": "Objective section maps directly to extracted observations"
          },
          {
            "claim_id": "CLM-0003",
            "claim_text": "Recommended action: Correlate symptoms with objective findings and timeline",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0004",
            "claim_text": "Recommended action: Prioritize evidence-backed differential items",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0005",
            "claim_text": "Recommended action: Collect missing objective data for unresolved uncertainty",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0006",
            "claim_text": "Recommended action: Apply verifier patch list before release",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0007",
            "claim_text": "Recommended action: Keep genotype-dependent recommendations caveated",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          }
        ],
        "sensitivity_map": [
          {
            "problem": "Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "sensitivity_class": "medium",
            "fragile_on": [
              "single-modality evidence"
            ]
          }
        ],
        "uncertainty_and_escalation_guidance": "Escalate when evidence remains weak for high-impact recommendations. Escalation to medical doctors is required.",
        "provenance": {
          "patient_id": "b8dd1798-beef-094d-1be4-f90ee0e6b7d5",
          "generated_at": "2026-02-24T04:25:18.461957+00:00",
          "pipeline": "medagent_v2_blackboard",
          "tooling": {
            "medgemma": "v2-reporter-medgemma-local",
            "biomcp": "v2-policy-biomcp-sdk-strict-no-fallback",
            "verifier": "v2-rules-only",
            "critic_enabled": false,
            "causal_postcheck": true
          },
          "blackboard": {
            "patient_id": "b8dd1798-beef-094d-1be4-f90ee0e6b7d5",
            "revision_id": 2,
            "patient_summary": {
              "timeline": [
                {
                  "t": "1926-06-19T02:05:40-04:00",
                  "encounter_type": "AMB",
                  "ehr_excerpt": "Patient demographics: gender=male, birth_date=1925-11-14\nKnown conditions: Chronic paralysis due to lesion of spinal cord, Body mass index 30+ - obesity (finding), Osteoporosis (disorder), Hyperlipidemia, Stroke, Numbness of face (finding), Impaired cognition (finding), Abnormal gait (finding), Silent micro-hemorrhage of brain (disorder), Coronary Heart Disease\nMedications: Simvastatin 10 MG Oral ",
                  "imaging_count": 1,
                  "variant_count": 25
                }
              ],
              "key_vitals": [],
              "key_labs": [],
              "phenotype_keywords": []
            },
            "medgemma_report": {
              "findings": [
                "Patient demographics: gender=male, birth_date=1925-11-14\nKnown conditions: Chronic paralysis due to lesion of spinal cord, Body mass index 30+ - obesity (finding), Osteoporosis (disorder), Hyperlipidemia, Stroke, Numbness of face (finding), Impaired cognition (finding), Abnormal gait (finding), Silent micro-hemorrhage of brain (disorder), Coronary Heart Disease\nMedications: Simvastatin 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet,"
              ],
              "candidate_assessments": [
                "Undifferentiated syndrome requiring additional objective data (hypothesis)"
              ],
              "supporting_observations": [
                "DICOM"
              ],
              "notes": [
                "Revision focus applied: Objective/subjective narrative lacks explicit negatives",
                "No genotype assertions included by reporter policy",
                "No literature-based assertions included by reporter policy",
                "MedGemma enabled but inference fallback was applied"
              ]
            },
            "genotype_report": {
              "interpretations": [
                "Variant hypothesis: CYP4A11 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: CYP4A11 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: PCSK9 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004 | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: PCSK9 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004 | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: Unlisted (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: Unlisted (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: MIA3 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cel | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: MIA3 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cel | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0"
              ],
              "hypotheses": [
                {
                  "hypothesis": "CYP4A11 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "CYP4A11 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "PCSK9 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004\nAbstract: Corresponding Author\nPublication State: peer_reviewed\nSource: PubMed\nPubmed Url: https://pubmed.ncbi.nlm.nih.gov/38094681/\nPmc Url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714159/\nDoi Url: https://doi.org/10.1016/j.jacbts.2023.08.004\nAuthors: Ungvari Z\n\n# Record 2\nPmid: 28846236\nTitle: PCSK9 Inhibitors\nJournal:\nDate: 2022-05-13T00:00:00Z\nAbstract:\n  Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an\n  important regulator of cholesterol metabolism. In the United States, 2\n  fully humanized monoclo",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "PCSK9 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004\nAbstract: Corresponding Author\nPublication State: peer_reviewed\nSource: PubMed\nPubmed Url: https://pubmed.ncbi.nlm.nih.gov/38094681/\nPmc Url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714159/\nDoi Url: https://doi.org/10.1016/j.jacbts.2023.08.004\nAuthors: Ungvari Z\n\n# Record 2\nPmid: 28846236\nTitle: PCSK9 Inhibitors\nJournal:\nDate: 2022-05-13T00:00:00Z\nAbstract:\n  Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an\n  important regulator of cholesterol metabolism. In the United States, 2\n  fully humanized monoclo",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "Unlisted may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "Unlisted may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "MIA3 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cell Sci\nDate: 2021-09-01T00:00:00Z\nDoi: 10.1242/jcs.259075\nAbstract:\n  ABSTRACT\n\n  Complex machinery is required to drive secretory cargo export from the\n  endoplasmic reticulum (ER), which is an essential process in eukaryotic\n  cells. In vertebrates, the MIA3 gene encodes two major forms of\n  transport and Golgi organization protein 1 (TANGO1S and TANGO1L), which\n  have previously been implicated in selective trafficking of procollagen.\n  Using genome engineering of human cells, light microscopy, secretion\n  assays, genomics and prote",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "MIA3 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cell Sci\nDate: 2021-09-01T00:00:00Z\nDoi: 10.1242/jcs.259075\nAbstract:\n  ABSTRACT\n\n  Complex machinery is required to drive secretory cargo export from the\n  endoplasmic reticulum (ER), which is an essential process in eukaryotic\n  cells. In vertebrates, the MIA3 gene encodes two major forms of\n  transport and Golgi organization protein 1 (TANGO1S and TANGO1L), which\n  have previously been implicated in selective trafficking of procollagen.\n  Using genome engineering of human cells, light microscopy, secretion\n  assays, genomics and prote",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                }
              ],
              "actionability_caveats": [
                "No therapeutic action should be based on genotype alone",
                "Conflict across sources should downgrade confidence"
              ],
              "biomcp_query_count": 8,
              "biomcp_empty_count": 0
            },
            "draft_soap": {
              "subjective": "Patient demographics: gender=male, birth_date=1925-11-14\nKnown conditions: Chronic paralysis due to lesion of spinal cord, Body mass index 30+ - obesity (finding), Osteoporosis (disorder), Hyperlipidemia, Stroke, Numbness of face (finding), Impaired cognition (finding), Abnormal gait (finding), Silent micro-hemorrhage of brain (disorder), Coronary Heart Disease\nMedications: Simvastatin 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet,",
              "objective": "DICOM",
              "assessment": "Undifferentiated syndrome requiring additional objective data (hypothesis); Genotype interpretation included as supporting evidence only; Verifier-requested updates addressed",
              "plan": "Correlate symptoms with objective findings and timeline; Prioritize evidence-backed differential items; Collect missing objective data for unresolved uncertainty; Apply verifier patch list before release; Keep genotype-dependent recommendations caveated",
              "differential_ranked": [
                "Undifferentiated syndrome requiring additional objective data (hypothesis)"
              ],
              "open_questions": [
                "What key negatives are still missing?",
                "Any temporal mismatch between symptoms and imaging findings?",
                "Any high-risk recommendation lacking strong evidence?"
              ],
              "confidence_score": 0.6
            },
            "claims_ledger": [
              {
                "claim_id": "CLM-0001",
                "claim_text": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
                "claim_type": "Inferred",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "ehr_or_imaging",
                    "source_id": "medgemma_report",
                    "quote_or_summary": "DICOM",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Differential item derived from integrated EHR+image narrative",
                "uncertainty": "Requires verifier consistency check",
                "depends_on_claim_ids": []
              },
              {
                "claim_id": "CLM-0002",
                "claim_text": "Objective summary: DICOM",
                "claim_type": "Observed",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "patient_summary",
                    "source_id": "patient_summary",
                    "quote_or_summary": "Derived from timeline/labs/vitals summary",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Objective section maps directly to extracted observations",
                "uncertainty": "May omit missing negatives",
                "depends_on_claim_ids": []
              },
              {
                "claim_id": "CLM-0003",
                "claim_text": "Recommended action: Correlate symptoms with objective findings and timeline",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0004",
                "claim_text": "Recommended action: Prioritize evidence-backed differential items",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0005",
                "claim_text": "Recommended action: Collect missing objective data for unresolved uncertainty",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0006",
                "claim_text": "Recommended action: Apply verifier patch list before release",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0007",
                "claim_text": "Recommended action: Keep genotype-dependent recommendations caveated",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              }
            ],
            "verifier_report": {
              "status": "FAIL",
              "patch_list": [
                {
                  "claim_id": "N/A",
                  "issue_type": "missing_negative",
                  "message": "Objective/subjective narrative lacks explicit negatives",
                  "suggested_fix": "Add key negatives or document that negatives are unavailable"
                }
              ],
              "check_summary": {
                "claim_count": 7,
                "patch_count": 1
              }
            },
            "citations": [
              {
                "citation_id": "biomcp-gene_disease_association-1",
                "intent": "GENE_DISEASE_ASSOCIATION",
                "query": "CYP4A11 phenotype association clinical relevance",
                "source": "biomcp",
                "summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                "metadata": {
                  "backend": "biomcp_sdk",
                  "source_id": "biomcp-1",
                  "ladder_step": 1,
                  "sdk_ok": true,
                  "sdk_attempted_calls": [
                    "biomcp.articles.search.search_articles(request)"
                  ],
                  "sdk_errors": []
                }
              }
            ],
            "audit_log": [
              {
                "timestamp_utc": "2026-02-24T04:25:10.747323+00:00",
                "agent": "orchestrator_v2",
                "action": "init_blackboard",
                "details": {
                  "timeline_events": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:10.753309+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:16.150386+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 8,
                  "citations": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:16.150598+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:16.150690+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:16.150864+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 6
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:16.390460+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:16.395759+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:16.809942+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 8,
                  "citations": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:16.809954+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:16.810053+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:16.810250+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 7
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:17.106234+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:17.111263+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:18.147827+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 8,
                  "citations": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:18.147840+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 2
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:18.147955+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:18.148149+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 7
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:18.461746+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:18.461903+00:00",
                "agent": "orchestrator_v2",
                "action": "max_revisions_reached",
                "details": {
                  "revision": 2,
                  "high_stakes": false,
                  "verifier_status": "FAIL"
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:18.461933+00:00",
                "agent": "orchestrator_v2",
                "action": "causal_postcheck",
                "details": {
                  "findings": 1
                }
              }
            ],
            "escalate_to_doctor": true,
            "critic_report": {}
          }
        }
      },
      "kg": {
        "backend": "dashboard",
        "nodes": [
          {
            "id": "patient",
            "label": "b8dd1798-beef-094d-1be4-f90ee0e6b7d5",
            "type": "patient"
          },
          {
            "id": "p1",
            "label": "Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "type": "problem"
          },
          {
            "id": "e1",
            "label": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "type": "evidence"
          },
          {
            "id": "e2",
            "label": "Objective summary: DICOM",
            "type": "evidence"
          },
          {
            "id": "e3",
            "label": "Recommended action: Correlate symptoms with objective findings and timeline",
            "type": "evidence"
          },
          {
            "id": "e4",
            "label": "Recommended action: Prioritize evidence-backed differential items",
            "type": "evidence"
          },
          {
            "id": "e5",
            "label": "Recommended action: Collect missing objective data for unresolved uncertainty",
            "type": "evidence"
          },
          {
            "id": "e6",
            "label": "Recommended action: Apply verifier patch list before release",
            "type": "evidence"
          },
          {
            "id": "e7",
            "label": "Recommended action: Keep genotype-dependent recommendations caveated",
            "type": "evidence"
          },
          {
            "id": "pl1",
            "label": "Prioritize evidence-backed differential items",
            "type": "plan"
          },
          {
            "id": "pl2",
            "label": "Collect targeted objective diagnostics",
            "type": "plan"
          },
          {
            "id": "pl3",
            "label": "Reassess with reconciled cross-modal timeline",
            "type": "plan"
          },
          {
            "id": "s1",
            "label": "Undifferentiated syndrome requiring additional objective data (hypothesis): medium",
            "type": "sensitivity"
          }
        ],
        "edges": [
          {
            "source": "patient",
            "target": "p1",
            "relation": "has_problem"
          },
          {
            "source": "e1",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e2",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e3",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e4",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e5",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e6",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e7",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "pl1",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "pl2",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "pl3",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "s1",
            "target": "patient",
            "relation": "robustness"
          }
        ]
      }
    },
    {
      "patient_id": "967d5226-f8c4-60a8-b882-6ef803af88a6",
      "patient_meta": {
        "modalities": [
          "fhir",
          "dicom",
          "genomics"
        ],
        "n_dicom_files": 1,
        "n_variants_loaded": 25,
        "outcome": "alive_or_unknown"
      },
      "evaluation": {
        "must_verify_count": 6,
        "must_verify_pass_rate": 1.0,
        "must_verify_weak_rate": 0.0,
        "must_verify_fail_rate": 0.0,
        "problem_count": 1,
        "sensitivity_count": 1
      },
      "result": {
        "soap_final": "S: Patient demographics: gender=male, birth_date=1930-04-29\nKnown conditions: Diabetes, Anemia (disorder), Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Neuropathy due to type 2 diabetes mellitus (disorder), Chronic sinusitis (disorder), Hyperglycemia (disorder), Prediabetes, Hyperlipidemia, Numbness of face (finding)\nMedications: Vitamin B 12 5 MG/ML Injectable Solution, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, 24 HR Metformin hydrochloride 500 MG Exte\nO: DICOM\nA: Undifferentiated syndrome requiring additional objective data (hypothesis); Genotype interpretation included as supporting evidence only; Verifier-requested updates addressed\nP: Correlate symptoms with objective findings and timeline; Prioritize evidence-backed differential items; Collect missing objective data for unresolved uncertainty; Apply verifier patch list before release; Keep genotype-dependent recommendations caveated",
        "problem_list_ranked": [
          "Undifferentiated syndrome requiring additional objective data (hypothesis)"
        ],
        "plan_options_ranked_non_prescriptive": [
          "Prioritize evidence-backed differential items",
          "Collect targeted objective diagnostics",
          "Reassess with reconciled cross-modal timeline"
        ],
        "evidence_table": [
          {
            "claim_id": "CLM-0001",
            "claim_text": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "category": "inferred",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "medgemma_report"
            ],
            "resolution": "Differential item derived from integrated EHR+image narrative"
          },
          {
            "claim_id": "CLM-0002",
            "claim_text": "Objective summary: DICOM",
            "category": "observed",
            "must_verify": false,
            "status": "pass",
            "evidence_ids": [
              "patient_summary"
            ],
            "resolution": "Objective section maps directly to extracted observations"
          },
          {
            "claim_id": "CLM-0003",
            "claim_text": "Recommended action: Correlate symptoms with objective findings and timeline",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0004",
            "claim_text": "Recommended action: Prioritize evidence-backed differential items",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0005",
            "claim_text": "Recommended action: Collect missing objective data for unresolved uncertainty",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0006",
            "claim_text": "Recommended action: Apply verifier patch list before release",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0007",
            "claim_text": "Recommended action: Keep genotype-dependent recommendations caveated",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          }
        ],
        "sensitivity_map": [
          {
            "problem": "Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "sensitivity_class": "medium",
            "fragile_on": [
              "single-modality evidence"
            ]
          }
        ],
        "uncertainty_and_escalation_guidance": "Escalate when evidence remains weak for high-impact recommendations. Escalation to medical doctors is required.",
        "provenance": {
          "patient_id": "967d5226-f8c4-60a8-b882-6ef803af88a6",
          "generated_at": "2026-02-24T04:25:22.770385+00:00",
          "pipeline": "medagent_v2_blackboard",
          "tooling": {
            "medgemma": "v2-reporter-medgemma-local",
            "biomcp": "v2-policy-biomcp-sdk-strict-no-fallback",
            "verifier": "v2-rules-only",
            "critic_enabled": false,
            "causal_postcheck": true
          },
          "blackboard": {
            "patient_id": "967d5226-f8c4-60a8-b882-6ef803af88a6",
            "revision_id": 2,
            "patient_summary": {
              "timeline": [
                {
                  "t": "1964-07-14T17:11:32-04:00",
                  "encounter_type": "AMB",
                  "ehr_excerpt": "Patient demographics: gender=male, birth_date=1930-04-29\nKnown conditions: Diabetes, Anemia (disorder), Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Neuropathy due to type 2 diabetes mellitus (disorder), Chronic sinusitis (disorder), Hyperglycemia (disorder), Prediabetes, Hyperlipidemia, Numbness of face (finding)\nMedications: Vitamin B 12 5 MG/ML Injectable Solution, 24 HR Me",
                  "imaging_count": 1,
                  "variant_count": 25
                }
              ],
              "key_vitals": [],
              "key_labs": [],
              "phenotype_keywords": []
            },
            "medgemma_report": {
              "findings": [
                "Patient demographics: gender=male, birth_date=1930-04-29\nKnown conditions: Diabetes, Anemia (disorder), Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Neuropathy due to type 2 diabetes mellitus (disorder), Chronic sinusitis (disorder), Hyperglycemia (disorder), Prediabetes, Hyperlipidemia, Numbness of face (finding)\nMedications: Vitamin B 12 5 MG/ML Injectable Solution, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, 24 HR Metformin hydrochloride 500 MG Exte"
              ],
              "candidate_assessments": [
                "Undifferentiated syndrome requiring additional objective data (hypothesis)"
              ],
              "supporting_observations": [
                "DICOM"
              ],
              "notes": [
                "Revision focus applied: Objective/subjective narrative lacks explicit negatives",
                "No genotype assertions included by reporter policy",
                "No literature-based assertions included by reporter policy",
                "MedGemma enabled but inference fallback was applied"
              ]
            },
            "genotype_report": {
              "interpretations": [
                "Variant hypothesis: CYP4A11 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: CYP4A11 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: PCSK9 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004 | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: PCSK9 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004 | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: Unlisted (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: Unlisted (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: MIA3 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cel | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: MIA3 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cel | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0"
              ],
              "hypotheses": [
                {
                  "hypothesis": "CYP4A11 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "CYP4A11 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "PCSK9 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004\nAbstract: Corresponding Author\nPublication State: peer_reviewed\nSource: PubMed\nPubmed Url: https://pubmed.ncbi.nlm.nih.gov/38094681/\nPmc Url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714159/\nDoi Url: https://doi.org/10.1016/j.jacbts.2023.08.004\nAuthors: Ungvari Z\n\n# Record 2\nPmid: 28846236\nTitle: PCSK9 Inhibitors\nJournal:\nDate: 2022-05-13T00:00:00Z\nAbstract:\n  Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an\n  important regulator of cholesterol metabolism. In the United States, 2\n  fully humanized monoclo",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "PCSK9 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004\nAbstract: Corresponding Author\nPublication State: peer_reviewed\nSource: PubMed\nPubmed Url: https://pubmed.ncbi.nlm.nih.gov/38094681/\nPmc Url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714159/\nDoi Url: https://doi.org/10.1016/j.jacbts.2023.08.004\nAuthors: Ungvari Z\n\n# Record 2\nPmid: 28846236\nTitle: PCSK9 Inhibitors\nJournal:\nDate: 2022-05-13T00:00:00Z\nAbstract:\n  Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an\n  important regulator of cholesterol metabolism. In the United States, 2\n  fully humanized monoclo",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "Unlisted may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "Unlisted may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "MIA3 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cell Sci\nDate: 2021-09-01T00:00:00Z\nDoi: 10.1242/jcs.259075\nAbstract:\n  ABSTRACT\n\n  Complex machinery is required to drive secretory cargo export from the\n  endoplasmic reticulum (ER), which is an essential process in eukaryotic\n  cells. In vertebrates, the MIA3 gene encodes two major forms of\n  transport and Golgi organization protein 1 (TANGO1S and TANGO1L), which\n  have previously been implicated in selective trafficking of procollagen.\n  Using genome engineering of human cells, light microscopy, secretion\n  assays, genomics and prote",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "MIA3 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cell Sci\nDate: 2021-09-01T00:00:00Z\nDoi: 10.1242/jcs.259075\nAbstract:\n  ABSTRACT\n\n  Complex machinery is required to drive secretory cargo export from the\n  endoplasmic reticulum (ER), which is an essential process in eukaryotic\n  cells. In vertebrates, the MIA3 gene encodes two major forms of\n  transport and Golgi organization protein 1 (TANGO1S and TANGO1L), which\n  have previously been implicated in selective trafficking of procollagen.\n  Using genome engineering of human cells, light microscopy, secretion\n  assays, genomics and prote",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                }
              ],
              "actionability_caveats": [
                "No therapeutic action should be based on genotype alone",
                "Conflict across sources should downgrade confidence"
              ],
              "biomcp_query_count": 8,
              "biomcp_empty_count": 0
            },
            "draft_soap": {
              "subjective": "Patient demographics: gender=male, birth_date=1930-04-29\nKnown conditions: Diabetes, Anemia (disorder), Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Neuropathy due to type 2 diabetes mellitus (disorder), Chronic sinusitis (disorder), Hyperglycemia (disorder), Prediabetes, Hyperlipidemia, Numbness of face (finding)\nMedications: Vitamin B 12 5 MG/ML Injectable Solution, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, 24 HR Metformin hydrochloride 500 MG Exte",
              "objective": "DICOM",
              "assessment": "Undifferentiated syndrome requiring additional objective data (hypothesis); Genotype interpretation included as supporting evidence only; Verifier-requested updates addressed",
              "plan": "Correlate symptoms with objective findings and timeline; Prioritize evidence-backed differential items; Collect missing objective data for unresolved uncertainty; Apply verifier patch list before release; Keep genotype-dependent recommendations caveated",
              "differential_ranked": [
                "Undifferentiated syndrome requiring additional objective data (hypothesis)"
              ],
              "open_questions": [
                "What key negatives are still missing?",
                "Any temporal mismatch between symptoms and imaging findings?",
                "Any high-risk recommendation lacking strong evidence?"
              ],
              "confidence_score": 0.6
            },
            "claims_ledger": [
              {
                "claim_id": "CLM-0001",
                "claim_text": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
                "claim_type": "Inferred",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "ehr_or_imaging",
                    "source_id": "medgemma_report",
                    "quote_or_summary": "DICOM",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Differential item derived from integrated EHR+image narrative",
                "uncertainty": "Requires verifier consistency check",
                "depends_on_claim_ids": []
              },
              {
                "claim_id": "CLM-0002",
                "claim_text": "Objective summary: DICOM",
                "claim_type": "Observed",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "patient_summary",
                    "source_id": "patient_summary",
                    "quote_or_summary": "Derived from timeline/labs/vitals summary",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Objective section maps directly to extracted observations",
                "uncertainty": "May omit missing negatives",
                "depends_on_claim_ids": []
              },
              {
                "claim_id": "CLM-0003",
                "claim_text": "Recommended action: Correlate symptoms with objective findings and timeline",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0004",
                "claim_text": "Recommended action: Prioritize evidence-backed differential items",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0005",
                "claim_text": "Recommended action: Collect missing objective data for unresolved uncertainty",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0006",
                "claim_text": "Recommended action: Apply verifier patch list before release",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0007",
                "claim_text": "Recommended action: Keep genotype-dependent recommendations caveated",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              }
            ],
            "verifier_report": {
              "status": "FAIL",
              "patch_list": [
                {
                  "claim_id": "N/A",
                  "issue_type": "missing_negative",
                  "message": "Objective/subjective narrative lacks explicit negatives",
                  "suggested_fix": "Add key negatives or document that negatives are unavailable"
                }
              ],
              "check_summary": {
                "claim_count": 7,
                "patch_count": 1
              }
            },
            "citations": [
              {
                "citation_id": "biomcp-gene_disease_association-1",
                "intent": "GENE_DISEASE_ASSOCIATION",
                "query": "CYP4A11 phenotype association clinical relevance",
                "source": "biomcp",
                "summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                "metadata": {
                  "backend": "biomcp_sdk",
                  "source_id": "biomcp-1",
                  "ladder_step": 1,
                  "sdk_ok": true,
                  "sdk_attempted_calls": [
                    "biomcp.articles.search.search_articles(request)"
                  ],
                  "sdk_errors": []
                }
              }
            ],
            "audit_log": [
              {
                "timestamp_utc": "2026-02-24T04:25:18.780610+00:00",
                "agent": "orchestrator_v2",
                "action": "init_blackboard",
                "details": {
                  "timeline_events": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:18.786058+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:19.849395+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 8,
                  "citations": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:19.849619+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:19.849715+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:19.849902+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 6
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:20.082275+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:20.088324+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:21.135818+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 8,
                  "citations": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:21.135835+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:21.135949+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:21.136140+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 7
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:21.456137+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:21.462007+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.445370+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 8,
                  "citations": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.445382+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 2
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.445474+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.445661+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 7
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.770158+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.770316+00:00",
                "agent": "orchestrator_v2",
                "action": "max_revisions_reached",
                "details": {
                  "revision": 2,
                  "high_stakes": false,
                  "verifier_status": "FAIL"
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.770357+00:00",
                "agent": "orchestrator_v2",
                "action": "causal_postcheck",
                "details": {
                  "findings": 1
                }
              }
            ],
            "escalate_to_doctor": true,
            "critic_report": {}
          }
        }
      },
      "kg": {
        "backend": "dashboard",
        "nodes": [
          {
            "id": "patient",
            "label": "967d5226-f8c4-60a8-b882-6ef803af88a6",
            "type": "patient"
          },
          {
            "id": "p1",
            "label": "Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "type": "problem"
          },
          {
            "id": "e1",
            "label": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "type": "evidence"
          },
          {
            "id": "e2",
            "label": "Objective summary: DICOM",
            "type": "evidence"
          },
          {
            "id": "e3",
            "label": "Recommended action: Correlate symptoms with objective findings and timeline",
            "type": "evidence"
          },
          {
            "id": "e4",
            "label": "Recommended action: Prioritize evidence-backed differential items",
            "type": "evidence"
          },
          {
            "id": "e5",
            "label": "Recommended action: Collect missing objective data for unresolved uncertainty",
            "type": "evidence"
          },
          {
            "id": "e6",
            "label": "Recommended action: Apply verifier patch list before release",
            "type": "evidence"
          },
          {
            "id": "e7",
            "label": "Recommended action: Keep genotype-dependent recommendations caveated",
            "type": "evidence"
          },
          {
            "id": "pl1",
            "label": "Prioritize evidence-backed differential items",
            "type": "plan"
          },
          {
            "id": "pl2",
            "label": "Collect targeted objective diagnostics",
            "type": "plan"
          },
          {
            "id": "pl3",
            "label": "Reassess with reconciled cross-modal timeline",
            "type": "plan"
          },
          {
            "id": "s1",
            "label": "Undifferentiated syndrome requiring additional objective data (hypothesis): medium",
            "type": "sensitivity"
          }
        ],
        "edges": [
          {
            "source": "patient",
            "target": "p1",
            "relation": "has_problem"
          },
          {
            "source": "e1",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e2",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e3",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e4",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e5",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e6",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e7",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "pl1",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "pl2",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "pl3",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "s1",
            "target": "patient",
            "relation": "robustness"
          }
        ]
      }
    },
    {
      "patient_id": "990db43c-4604-a27c-4153-bfa9ef42a9e2",
      "patient_meta": {
        "modalities": [
          "fhir"
        ],
        "n_dicom_files": 0,
        "n_variants_loaded": 0,
        "outcome": "deceased"
      },
      "evaluation": {
        "must_verify_count": 6,
        "must_verify_pass_rate": 0.0,
        "must_verify_weak_rate": 0.0,
        "must_verify_fail_rate": 1.0,
        "problem_count": 1,
        "sensitivity_count": 1
      },
      "result": {
        "soap_final": "S: Patient demographics: gender=male, birth_date=1934-02-27\nKnown conditions: Hypertension, Body mass index 30+ - obesity (finding), Prediabetes, Anemia (disorder), Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Viral sinusitis (disorder), Viral sinusitis (disorder), Acute bronchitis (disorder), Acute bronchitis (disorder)\nMedications: lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tabl\nO: Objective evidence limited\nA: Undifferentiated syndrome requiring additional objective data (hypothesis); Genotype interpretation included as supporting evidence only; Verifier-requested updates addressed\nP: Correlate symptoms with objective findings and timeline; Prioritize evidence-backed differential items; Collect missing objective data for unresolved uncertainty; Apply verifier patch list before release; Keep genotype-dependent recommendations caveated",
        "problem_list_ranked": [
          "Undifferentiated syndrome requiring additional objective data (hypothesis)"
        ],
        "plan_options_ranked_non_prescriptive": [
          "Prioritize evidence-backed differential items",
          "Collect targeted objective diagnostics",
          "Reassess with reconciled cross-modal timeline"
        ],
        "evidence_table": [
          {
            "claim_id": "CLM-0001",
            "claim_text": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "category": "inferred",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Differential item derived from integrated EHR+image narrative"
          },
          {
            "claim_id": "CLM-0002",
            "claim_text": "Objective summary: Objective evidence limited",
            "category": "observed",
            "must_verify": false,
            "status": "pass",
            "evidence_ids": [
              "patient_summary"
            ],
            "resolution": "Objective section maps directly to extracted observations"
          },
          {
            "claim_id": "CLM-0003",
            "claim_text": "Recommended action: Correlate symptoms with objective findings and timeline",
            "category": "recommended",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0004",
            "claim_text": "Recommended action: Prioritize evidence-backed differential items",
            "category": "recommended",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0005",
            "claim_text": "Recommended action: Collect missing objective data for unresolved uncertainty",
            "category": "recommended",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0006",
            "claim_text": "Recommended action: Apply verifier patch list before release",
            "category": "recommended",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0007",
            "claim_text": "Recommended action: Keep genotype-dependent recommendations caveated",
            "category": "recommended",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Plan recommendation from supervisor synthesis"
          }
        ],
        "sensitivity_map": [
          {
            "problem": "Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "sensitivity_class": "medium",
            "fragile_on": [
              "single-modality evidence"
            ]
          }
        ],
        "uncertainty_and_escalation_guidance": "Escalate when evidence remains weak for high-impact recommendations. Escalation to medical doctors is required.",
        "provenance": {
          "patient_id": "990db43c-4604-a27c-4153-bfa9ef42a9e2",
          "generated_at": "2026-02-24T04:25:23.656568+00:00",
          "pipeline": "medagent_v2_blackboard",
          "tooling": {
            "medgemma": "v2-reporter-medgemma-local",
            "biomcp": "v2-policy-biomcp-sdk-strict-no-fallback",
            "verifier": "v2-rules-only",
            "critic_enabled": false,
            "causal_postcheck": true
          },
          "blackboard": {
            "patient_id": "990db43c-4604-a27c-4153-bfa9ef42a9e2",
            "revision_id": 2,
            "patient_summary": {
              "timeline": [
                {
                  "t": "1952-04-22T13:09:19-05:00",
                  "encounter_type": "AMB",
                  "ehr_excerpt": "Patient demographics: gender=male, birth_date=1934-02-27\nKnown conditions: Hypertension, Body mass index 30+ - obesity (finding), Prediabetes, Anemia (disorder), Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Viral sinusitis (disorder), Viral sinusitis (disorder), Acute bronchitis (disorder), Acute bronchitis (disorder)\nMedications: lisinopril 10 MG Oral Tablet, lisinopril 10 MG",
                  "imaging_count": 0,
                  "variant_count": 0
                }
              ],
              "key_vitals": [],
              "key_labs": [],
              "phenotype_keywords": []
            },
            "medgemma_report": {
              "findings": [
                "Patient demographics: gender=male, birth_date=1934-02-27\nKnown conditions: Hypertension, Body mass index 30+ - obesity (finding), Prediabetes, Anemia (disorder), Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Viral sinusitis (disorder), Viral sinusitis (disorder), Acute bronchitis (disorder), Acute bronchitis (disorder)\nMedications: lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tabl"
              ],
              "candidate_assessments": [
                "Undifferentiated syndrome requiring additional objective data (hypothesis)"
              ],
              "supporting_observations": [],
              "notes": [
                "Revision focus applied: Objective/subjective narrative lacks explicit negatives",
                "No genotype assertions included by reporter policy",
                "No literature-based assertions included by reporter policy",
                "MedGemma enabled but inference fallback was applied"
              ]
            },
            "genotype_report": {
              "interpretations": [
                "No genotype variants available"
              ],
              "hypotheses": [],
              "actionability_caveats": [
                "No genotype-derived actionability conclusions"
              ],
              "biomcp_query_count": 0,
              "biomcp_empty_count": 0
            },
            "draft_soap": {
              "subjective": "Patient demographics: gender=male, birth_date=1934-02-27\nKnown conditions: Hypertension, Body mass index 30+ - obesity (finding), Prediabetes, Anemia (disorder), Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Viral sinusitis (disorder), Viral sinusitis (disorder), Acute bronchitis (disorder), Acute bronchitis (disorder)\nMedications: lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tablet, lisinopril 10 MG Oral Tabl",
              "objective": "Objective evidence limited",
              "assessment": "Undifferentiated syndrome requiring additional objective data (hypothesis); Genotype interpretation included as supporting evidence only; Verifier-requested updates addressed",
              "plan": "Correlate symptoms with objective findings and timeline; Prioritize evidence-backed differential items; Collect missing objective data for unresolved uncertainty; Apply verifier patch list before release; Keep genotype-dependent recommendations caveated",
              "differential_ranked": [
                "Undifferentiated syndrome requiring additional objective data (hypothesis)"
              ],
              "open_questions": [
                "What key negatives are still missing?",
                "Any temporal mismatch between symptoms and imaging findings?",
                "Any high-risk recommendation lacking strong evidence?"
              ],
              "confidence_score": 0.6
            },
            "claims_ledger": [
              {
                "claim_id": "CLM-0001",
                "claim_text": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
                "claim_type": "Inferred",
                "confidence": "Medium",
                "evidence_items": [],
                "reasoning": "Differential item derived from integrated EHR+image narrative",
                "uncertainty": "Requires verifier consistency check",
                "depends_on_claim_ids": []
              },
              {
                "claim_id": "CLM-0002",
                "claim_text": "Objective summary: Objective evidence limited",
                "claim_type": "Observed",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "patient_summary",
                    "source_id": "patient_summary",
                    "quote_or_summary": "Derived from timeline/labs/vitals summary",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Objective section maps directly to extracted observations",
                "uncertainty": "May omit missing negatives",
                "depends_on_claim_ids": []
              },
              {
                "claim_id": "CLM-0003",
                "claim_text": "Recommended action: Correlate symptoms with objective findings and timeline",
                "claim_type": "Recommended",
                "confidence": "Low",
                "evidence_items": [],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0004",
                "claim_text": "Recommended action: Prioritize evidence-backed differential items",
                "claim_type": "Recommended",
                "confidence": "Low",
                "evidence_items": [],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0005",
                "claim_text": "Recommended action: Collect missing objective data for unresolved uncertainty",
                "claim_type": "Recommended",
                "confidence": "Low",
                "evidence_items": [],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0006",
                "claim_text": "Recommended action: Apply verifier patch list before release",
                "claim_type": "Recommended",
                "confidence": "Low",
                "evidence_items": [],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0007",
                "claim_text": "Recommended action: Keep genotype-dependent recommendations caveated",
                "claim_type": "Recommended",
                "confidence": "Low",
                "evidence_items": [],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              }
            ],
            "verifier_report": {
              "status": "FAIL",
              "patch_list": [
                {
                  "claim_id": "N/A",
                  "issue_type": "missing_negative",
                  "message": "Objective/subjective narrative lacks explicit negatives",
                  "suggested_fix": "Add key negatives or document that negatives are unavailable"
                },
                {
                  "claim_id": "CLM-0001",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0003",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Recommended action: Correlate symptoms with objective findings and timeline",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0003",
                  "issue_type": "high_risk_weak_evidence",
                  "message": "Recommendation retained with low confidence",
                  "suggested_fix": "Add guideline/literature support or keep as explicit hypothesis"
                },
                {
                  "claim_id": "CLM-0004",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Recommended action: Prioritize evidence-backed differential items",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0004",
                  "issue_type": "high_risk_weak_evidence",
                  "message": "Recommendation retained with low confidence",
                  "suggested_fix": "Add guideline/literature support or keep as explicit hypothesis"
                },
                {
                  "claim_id": "CLM-0005",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Recommended action: Collect missing objective data for unresolved uncertainty",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0005",
                  "issue_type": "high_risk_weak_evidence",
                  "message": "Recommendation retained with low confidence",
                  "suggested_fix": "Add guideline/literature support or keep as explicit hypothesis"
                },
                {
                  "claim_id": "CLM-0006",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Recommended action: Apply verifier patch list before release",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0006",
                  "issue_type": "high_risk_weak_evidence",
                  "message": "Recommendation retained with low confidence",
                  "suggested_fix": "Add guideline/literature support or keep as explicit hypothesis"
                },
                {
                  "claim_id": "CLM-0007",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Recommended action: Keep genotype-dependent recommendations caveated",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                },
                {
                  "claim_id": "CLM-0007",
                  "issue_type": "high_risk_weak_evidence",
                  "message": "Recommendation retained with low confidence",
                  "suggested_fix": "Add guideline/literature support or keep as explicit hypothesis"
                }
              ],
              "check_summary": {
                "claim_count": 7,
                "patch_count": 12
              }
            },
            "citations": [],
            "audit_log": [
              {
                "timestamp_utc": "2026-02-24T04:25:22.792899+00:00",
                "agent": "orchestrator_v2",
                "action": "init_blackboard",
                "details": {
                  "timeline_events": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.798257+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.798440+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.798509+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.798588+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:22.798749+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 6
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.042831+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 10
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.047241+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.047262+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.047268+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.047382+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.047560+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 7
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.344728+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 12
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.349191+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.349210+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.349216+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 2
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.349330+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.349505+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 7
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.656373+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 12
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.656520+00:00",
                "agent": "orchestrator_v2",
                "action": "max_revisions_reached",
                "details": {
                  "revision": 2,
                  "high_stakes": false,
                  "verifier_status": "FAIL"
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.656545+00:00",
                "agent": "orchestrator_v2",
                "action": "causal_postcheck",
                "details": {
                  "findings": 1
                }
              }
            ],
            "escalate_to_doctor": true,
            "critic_report": {}
          }
        }
      },
      "kg": {
        "backend": "dashboard",
        "nodes": [
          {
            "id": "patient",
            "label": "990db43c-4604-a27c-4153-bfa9ef42a9e2",
            "type": "patient"
          },
          {
            "id": "p1",
            "label": "Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "type": "problem"
          },
          {
            "id": "e1",
            "label": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "type": "evidence"
          },
          {
            "id": "e2",
            "label": "Objective summary: Objective evidence limited",
            "type": "evidence"
          },
          {
            "id": "e3",
            "label": "Recommended action: Correlate symptoms with objective findings and timeline",
            "type": "evidence"
          },
          {
            "id": "e4",
            "label": "Recommended action: Prioritize evidence-backed differential items",
            "type": "evidence"
          },
          {
            "id": "e5",
            "label": "Recommended action: Collect missing objective data for unresolved uncertainty",
            "type": "evidence"
          },
          {
            "id": "e6",
            "label": "Recommended action: Apply verifier patch list before release",
            "type": "evidence"
          },
          {
            "id": "e7",
            "label": "Recommended action: Keep genotype-dependent recommendations caveated",
            "type": "evidence"
          },
          {
            "id": "pl1",
            "label": "Prioritize evidence-backed differential items",
            "type": "plan"
          },
          {
            "id": "pl2",
            "label": "Collect targeted objective diagnostics",
            "type": "plan"
          },
          {
            "id": "pl3",
            "label": "Reassess with reconciled cross-modal timeline",
            "type": "plan"
          },
          {
            "id": "s1",
            "label": "Undifferentiated syndrome requiring additional objective data (hypothesis): medium",
            "type": "sensitivity"
          }
        ],
        "edges": [
          {
            "source": "patient",
            "target": "p1",
            "relation": "has_problem"
          },
          {
            "source": "e1",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e2",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e3",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e4",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e5",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e6",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e7",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "pl1",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "pl2",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "pl3",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "s1",
            "target": "patient",
            "relation": "robustness"
          }
        ]
      }
    },
    {
      "patient_id": "08240b05-a834-d6ad-42ad-951210005628",
      "patient_meta": {
        "modalities": [
          "fhir",
          "genomics"
        ],
        "n_dicom_files": 0,
        "n_variants_loaded": 25,
        "outcome": "deceased"
      },
      "evaluation": {
        "must_verify_count": 6,
        "must_verify_pass_rate": 0.8333,
        "must_verify_weak_rate": 0.0,
        "must_verify_fail_rate": 0.1667,
        "problem_count": 1,
        "sensitivity_count": 1
      },
      "result": {
        "soap_final": "S: Patient demographics: gender=female, birth_date=1941-12-27\nKnown conditions: Chronic sinusitis (disorder), Hypertension, Diabetes, Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Anemia (disorder), Neuropathy due to type 2 diabetes mellitus (disorder), Hyperglycemia (disorder), Prediabetes, Miscarriage in first trimester\nMedications: lisinopril 10 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet, Hydrochl\nO: Objective evidence limited\nA: Undifferentiated syndrome requiring additional objective data (hypothesis); Genotype interpretation included as supporting evidence only; Verifier-requested updates addressed\nP: Correlate symptoms with objective findings and timeline; Prioritize evidence-backed differential items; Collect missing objective data for unresolved uncertainty; Apply verifier patch list before release; Keep genotype-dependent recommendations caveated",
        "problem_list_ranked": [
          "Undifferentiated syndrome requiring additional objective data (hypothesis)"
        ],
        "plan_options_ranked_non_prescriptive": [
          "Prioritize evidence-backed differential items",
          "Collect targeted objective diagnostics",
          "Reassess with reconciled cross-modal timeline"
        ],
        "evidence_table": [
          {
            "claim_id": "CLM-0001",
            "claim_text": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "category": "inferred",
            "must_verify": true,
            "status": "fail",
            "evidence_ids": [],
            "resolution": "Differential item derived from integrated EHR+image narrative"
          },
          {
            "claim_id": "CLM-0002",
            "claim_text": "Objective summary: Objective evidence limited",
            "category": "observed",
            "must_verify": false,
            "status": "pass",
            "evidence_ids": [
              "patient_summary"
            ],
            "resolution": "Objective section maps directly to extracted observations"
          },
          {
            "claim_id": "CLM-0003",
            "claim_text": "Recommended action: Correlate symptoms with objective findings and timeline",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0004",
            "claim_text": "Recommended action: Prioritize evidence-backed differential items",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0005",
            "claim_text": "Recommended action: Collect missing objective data for unresolved uncertainty",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0006",
            "claim_text": "Recommended action: Apply verifier patch list before release",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          },
          {
            "claim_id": "CLM-0007",
            "claim_text": "Recommended action: Keep genotype-dependent recommendations caveated",
            "category": "recommended",
            "must_verify": true,
            "status": "pass",
            "evidence_ids": [
              "biomcp-gene_disease_association-1"
            ],
            "resolution": "Plan recommendation from supervisor synthesis"
          }
        ],
        "sensitivity_map": [
          {
            "problem": "Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "sensitivity_class": "medium",
            "fragile_on": [
              "single-modality evidence"
            ]
          }
        ],
        "uncertainty_and_escalation_guidance": "Escalate when evidence remains weak for high-impact recommendations. Escalation to medical doctors is required.",
        "provenance": {
          "patient_id": "08240b05-a834-d6ad-42ad-951210005628",
          "generated_at": "2026-02-24T04:25:27.497099+00:00",
          "pipeline": "medagent_v2_blackboard",
          "tooling": {
            "medgemma": "v2-reporter-medgemma-local",
            "biomcp": "v2-policy-biomcp-sdk-strict-no-fallback",
            "verifier": "v2-rules-only",
            "critic_enabled": false,
            "causal_postcheck": true
          },
          "blackboard": {
            "patient_id": "08240b05-a834-d6ad-42ad-951210005628",
            "revision_id": 2,
            "patient_summary": {
              "timeline": [
                {
                  "t": "1949-07-13T12:14:30-04:00",
                  "encounter_type": "AMB",
                  "ehr_excerpt": "Patient demographics: gender=female, birth_date=1941-12-27\nKnown conditions: Chronic sinusitis (disorder), Hypertension, Diabetes, Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Anemia (disorder), Neuropathy due to type 2 diabetes mellitus (disorder), Hyperglycemia (disorder), Prediabetes, Miscarriage in first trimester\nMedications: lisinopril 10 MG Oral Tablet, Hydrochlorothiaz",
                  "imaging_count": 0,
                  "variant_count": 25
                }
              ],
              "key_vitals": [],
              "key_labs": [],
              "phenotype_keywords": []
            },
            "medgemma_report": {
              "findings": [
                "Patient demographics: gender=female, birth_date=1941-12-27\nKnown conditions: Chronic sinusitis (disorder), Hypertension, Diabetes, Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Anemia (disorder), Neuropathy due to type 2 diabetes mellitus (disorder), Hyperglycemia (disorder), Prediabetes, Miscarriage in first trimester\nMedications: lisinopril 10 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet, Hydrochl"
              ],
              "candidate_assessments": [
                "Undifferentiated syndrome requiring additional objective data (hypothesis)"
              ],
              "supporting_observations": [],
              "notes": [
                "Revision focus applied: Objective/subjective narrative lacks explicit negatives",
                "No genotype assertions included by reporter policy",
                "No literature-based assertions included by reporter policy",
                "MedGemma enabled but inference fallback was applied"
              ]
            },
            "genotype_report": {
              "interpretations": [
                "Variant hypothesis: CYP4A11 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: CYP4A11 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: PCSK9 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004 | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: PCSK9 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004 | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: Unlisted (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: Unlisted (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: MIA3 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cel | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0",
                "Variant hypothesis: MIA3 (Medium confidence)",
                "Evidence summaries: biomcp: # Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cel | biomcp: # Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T0"
              ],
              "hypotheses": [
                {
                  "hypothesis": "CYP4A11 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported",
                    "Revision focus addressed: Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "CYP4A11 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported",
                    "Revision focus addressed: Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "PCSK9 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported",
                    "Revision focus addressed: Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004\nAbstract: Corresponding Author\nPublication State: peer_reviewed\nSource: PubMed\nPubmed Url: https://pubmed.ncbi.nlm.nih.gov/38094681/\nPmc Url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714159/\nDoi Url: https://doi.org/10.1016/j.jacbts.2023.08.004\nAuthors: Ungvari Z\n\n# Record 2\nPmid: 28846236\nTitle: PCSK9 Inhibitors\nJournal:\nDate: 2022-05-13T00:00:00Z\nAbstract:\n  Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an\n  important regulator of cholesterol metabolism. In the United States, 2\n  fully humanized monoclo",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "PCSK9 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported",
                    "Revision focus addressed: Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 38094681\nPmcid: PMC10714159\nTitle: PCSK9 Inhibition\nJournal: JACC Basic Transl Sci\nDate: 2023-10-23T00:00:00Z\nDoi: 10.1016/j.jacbts.2023.08.004\nAbstract: Corresponding Author\nPublication State: peer_reviewed\nSource: PubMed\nPubmed Url: https://pubmed.ncbi.nlm.nih.gov/38094681/\nPmc Url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714159/\nDoi Url: https://doi.org/10.1016/j.jacbts.2023.08.004\nAuthors: Ungvari Z\n\n# Record 2\nPmid: 28846236\nTitle: PCSK9 Inhibitors\nJournal:\nDate: 2022-05-13T00:00:00Z\nAbstract:\n  Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an\n  important regulator of cholesterol metabolism. In the United States, 2\n  fully humanized monoclo",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "Unlisted may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported",
                    "Revision focus addressed: Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "Unlisted may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported",
                    "Revision focus addressed: Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n: # Record 1\nError: Error 400: [\"text is a mandatory parameter.\"]\n",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "MIA3 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported",
                    "Revision focus addressed: Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cell Sci\nDate: 2021-09-01T00:00:00Z\nDoi: 10.1242/jcs.259075\nAbstract:\n  ABSTRACT\n\n  Complex machinery is required to drive secretory cargo export from the\n  endoplasmic reticulum (ER), which is an essential process in eukaryotic\n  cells. In vertebrates, the MIA3 gene encodes two major forms of\n  transport and Golgi organization protein 1 (TANGO1S and TANGO1L), which\n  have previously been implicated in selective trafficking of procollagen.\n  Using genome engineering of human cells, light microscopy, secretion\n  assays, genomics and prote",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                },
                {
                  "hypothesis": "MIA3 may contribute to clinical phenotype",
                  "phenotype_links": [],
                  "evidence_strength": "Medium",
                  "caveats": [
                    "Genotype findings are supportive and must be integrated with phenotype and imaging",
                    "Insufficient evidence remains possible and should be explicitly reported",
                    "Revision focus addressed: Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)"
                  ],
                  "evidence_items": [
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 34350936\nPmcid: PMC8524724\nTitle:\n  A general role for TANGO1, encoded by MIA3, in secretory pathway\n  organization and function\nJournal: J Cell Sci\nDate: 2021-09-01T00:00:00Z\nDoi: 10.1242/jcs.259075\nAbstract:\n  ABSTRACT\n\n  Complex machinery is required to drive secretory cargo export from the\n  endoplasmic reticulum (ER), which is an essential process in eukaryotic\n  cells. In vertebrates, the MIA3 gene encodes two major forms of\n  transport and Golgi organization protein 1 (TANGO1S and TANGO1L), which\n  have previously been implicated in selective trafficking of procollagen.\n  Using genome engineering of human cells, light microscopy, secretion\n  assays, genomics and prote",
                      "method": "qual",
                      "strength_level": "moderate"
                    },
                    {
                      "source_type": "literature",
                      "source_id": "biomcp-gene_disease_association-1",
                      "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                      "method": "qual",
                      "strength_level": "moderate"
                    }
                  ]
                }
              ],
              "actionability_caveats": [
                "No therapeutic action should be based on genotype alone",
                "Conflict across sources should downgrade confidence"
              ],
              "biomcp_query_count": 8,
              "biomcp_empty_count": 0
            },
            "draft_soap": {
              "subjective": "Patient demographics: gender=female, birth_date=1941-12-27\nKnown conditions: Chronic sinusitis (disorder), Hypertension, Diabetes, Hypertriglyceridemia (disorder), Metabolic syndrome X (disorder), Anemia (disorder), Neuropathy due to type 2 diabetes mellitus (disorder), Hyperglycemia (disorder), Prediabetes, Miscarriage in first trimester\nMedications: lisinopril 10 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet, Hydrochl",
              "objective": "Objective evidence limited",
              "assessment": "Undifferentiated syndrome requiring additional objective data (hypothesis); Genotype interpretation included as supporting evidence only; Verifier-requested updates addressed",
              "plan": "Correlate symptoms with objective findings and timeline; Prioritize evidence-backed differential items; Collect missing objective data for unresolved uncertainty; Apply verifier patch list before release; Keep genotype-dependent recommendations caveated",
              "differential_ranked": [
                "Undifferentiated syndrome requiring additional objective data (hypothesis)"
              ],
              "open_questions": [
                "What key negatives are still missing?",
                "Any temporal mismatch between symptoms and imaging findings?",
                "Any high-risk recommendation lacking strong evidence?"
              ],
              "confidence_score": 0.6
            },
            "claims_ledger": [
              {
                "claim_id": "CLM-0001",
                "claim_text": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
                "claim_type": "Inferred",
                "confidence": "Medium",
                "evidence_items": [],
                "reasoning": "Differential item derived from integrated EHR+image narrative",
                "uncertainty": "Requires verifier consistency check",
                "depends_on_claim_ids": []
              },
              {
                "claim_id": "CLM-0002",
                "claim_text": "Objective summary: Objective evidence limited",
                "claim_type": "Observed",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "patient_summary",
                    "source_id": "patient_summary",
                    "quote_or_summary": "Derived from timeline/labs/vitals summary",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Objective section maps directly to extracted observations",
                "uncertainty": "May omit missing negatives",
                "depends_on_claim_ids": []
              },
              {
                "claim_id": "CLM-0003",
                "claim_text": "Recommended action: Correlate symptoms with objective findings and timeline",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0004",
                "claim_text": "Recommended action: Prioritize evidence-backed differential items",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0005",
                "claim_text": "Recommended action: Collect missing objective data for unresolved uncertainty",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0006",
                "claim_text": "Recommended action: Apply verifier patch list before release",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              },
              {
                "claim_id": "CLM-0007",
                "claim_text": "Recommended action: Keep genotype-dependent recommendations caveated",
                "claim_type": "Recommended",
                "confidence": "Medium",
                "evidence_items": [
                  {
                    "source_type": "literature",
                    "source_id": "biomcp-gene_disease_association-1",
                    "quote_or_summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                    "method": "qual",
                    "strength_level": "moderate"
                  }
                ],
                "reasoning": "Plan recommendation from supervisor synthesis",
                "uncertainty": "Recommendation remains provisional without strong supporting evidence",
                "depends_on_claim_ids": [
                  "CLM-0001"
                ]
              }
            ],
            "verifier_report": {
              "status": "FAIL",
              "patch_list": [
                {
                  "claim_id": "N/A",
                  "issue_type": "missing_negative",
                  "message": "Objective/subjective narrative lacks explicit negatives",
                  "suggested_fix": "Add key negatives or document that negatives are unavailable"
                },
                {
                  "claim_id": "CLM-0001",
                  "issue_type": "unsupported_claim",
                  "message": "Claim lacks evidence: Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
                  "suggested_fix": "Attach supporting evidence or downgrade confidence and uncertainty"
                }
              ],
              "check_summary": {
                "claim_count": 7,
                "patch_count": 2
              }
            },
            "citations": [
              {
                "citation_id": "biomcp-gene_disease_association-1",
                "intent": "GENE_DISEASE_ASSOCIATION",
                "query": "CYP4A11 phenotype association clinical relevance",
                "source": "biomcp",
                "summary": "# Record 1\nPmid: 40454940\nPmcid: PMC12191924\nTitle: A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11\nJournal: Biochem J\nDate: 2025-05-30T00:00:00Z\nDoi: 10.1042/BCJ20253130\nAbstract:\n  We aimed to create a high-throughput fluorimetric assay for the activity\n  of CYP4A11, the major 20-HETE-producing enzyme. To this end, we probed\n  3-(6-methoxynaphthalen-2-yl)acrylic acid (MONACRA) as a potential\n  CYP4A11 substrate. We studied its metabolism using human liver\n  microsomes (HLM) and recombinant P450 enzymes. O-demethylation of\n  MONACRA by cytochromes P450 creates 3-(6-hydroxynaphthalen-2-yl)acrylic\n  acid. The bright fluorescence of the product and its clear spectral\n  r",
                "metadata": {
                  "backend": "biomcp_sdk",
                  "source_id": "biomcp-1",
                  "ladder_step": 1,
                  "sdk_ok": true,
                  "sdk_attempted_calls": [
                    "biomcp.articles.search.search_articles(request)"
                  ],
                  "sdk_errors": []
                }
              }
            ],
            "audit_log": [
              {
                "timestamp_utc": "2026-02-24T04:25:23.975164+00:00",
                "agent": "orchestrator_v2",
                "action": "init_blackboard",
                "details": {
                  "timeline_events": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:23.980371+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:24.584573+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 8,
                  "citations": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:24.584785+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 0
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:24.584885+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:24.585065+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 6
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:24.848562+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 2
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:24.853937+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:25.883778+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 8,
                  "citations": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:25.883792+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:25.883904+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:25.884106+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 7
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:26.174345+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 2
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:26.180420+00:00",
                "agent": "a1_ehr_image_reporter",
                "action": "write_medgemma_report",
                "details": {
                  "assessments": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:27.192552+00:00",
                "agent": "a2_genotype_interpreter",
                "action": "write_genotype_report",
                "details": {
                  "variants": 8,
                  "citations": 1
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:27.192563+00:00",
                "agent": "orchestrator_v2",
                "action": "revision_start",
                "details": {
                  "revision": 2
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:27.192654+00:00",
                "agent": "a3_supervisor",
                "action": "write_draft_soap",
                "details": {
                  "differential": 1,
                  "confidence_score": 0.6,
                  "used_openai": false,
                  "confidence_script": ""
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:27.192853+00:00",
                "agent": "a4_evidence_assembler",
                "action": "write_claims_ledger",
                "details": {
                  "claims": 7
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:27.496830+00:00",
                "agent": "a5_verifier",
                "action": "write_verifier_report",
                "details": {
                  "status": "FAIL",
                  "patches": 2
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:27.497018+00:00",
                "agent": "orchestrator_v2",
                "action": "max_revisions_reached",
                "details": {
                  "revision": 2,
                  "high_stakes": false,
                  "verifier_status": "FAIL"
                }
              },
              {
                "timestamp_utc": "2026-02-24T04:25:27.497061+00:00",
                "agent": "orchestrator_v2",
                "action": "causal_postcheck",
                "details": {
                  "findings": 1
                }
              }
            ],
            "escalate_to_doctor": true,
            "critic_report": {}
          }
        }
      },
      "kg": {
        "backend": "dashboard",
        "nodes": [
          {
            "id": "patient",
            "label": "08240b05-a834-d6ad-42ad-951210005628",
            "type": "patient"
          },
          {
            "id": "p1",
            "label": "Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "type": "problem"
          },
          {
            "id": "e1",
            "label": "Differential includes: Undifferentiated syndrome requiring additional objective data (hypothesis)",
            "type": "evidence"
          },
          {
            "id": "e2",
            "label": "Objective summary: Objective evidence limited",
            "type": "evidence"
          },
          {
            "id": "e3",
            "label": "Recommended action: Correlate symptoms with objective findings and timeline",
            "type": "evidence"
          },
          {
            "id": "e4",
            "label": "Recommended action: Prioritize evidence-backed differential items",
            "type": "evidence"
          },
          {
            "id": "e5",
            "label": "Recommended action: Collect missing objective data for unresolved uncertainty",
            "type": "evidence"
          },
          {
            "id": "e6",
            "label": "Recommended action: Apply verifier patch list before release",
            "type": "evidence"
          },
          {
            "id": "e7",
            "label": "Recommended action: Keep genotype-dependent recommendations caveated",
            "type": "evidence"
          },
          {
            "id": "pl1",
            "label": "Prioritize evidence-backed differential items",
            "type": "plan"
          },
          {
            "id": "pl2",
            "label": "Collect targeted objective diagnostics",
            "type": "plan"
          },
          {
            "id": "pl3",
            "label": "Reassess with reconciled cross-modal timeline",
            "type": "plan"
          },
          {
            "id": "s1",
            "label": "Undifferentiated syndrome requiring additional objective data (hypothesis): medium",
            "type": "sensitivity"
          }
        ],
        "edges": [
          {
            "source": "patient",
            "target": "p1",
            "relation": "has_problem"
          },
          {
            "source": "e1",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e2",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e3",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e4",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e5",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e6",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "e7",
            "target": "patient",
            "relation": "supports"
          },
          {
            "source": "pl1",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "pl2",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "pl3",
            "target": "patient",
            "relation": "targets"
          },
          {
            "source": "s1",
            "target": "patient",
            "relation": "robustness"
          }
        ]
      }
    }
  ]
}